These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6247457)

  • 41. [Clinical studies on assay for Na-K ATPase in human blood cells. I. Erythrocyte Na-K ATPase assay in patients with thyroid dysfunction and in those with chronic renal failure].
    Ogasawara H; Nishikawa M
    Nihon Naibunpi Gakkai Zasshi; 1988 May; 64(5):329-39. PubMed ID: 2842203
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Canrenone as a partial agonist at the digitalis receptor site of sodium-potassium-activated adenosine triphosphatase.
    Finotti P; Palatini P
    J Pharmacol Exp Ther; 1981 Jun; 217(3):784-90. PubMed ID: 6262496
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Erythrocyte alkaline phosphatase in patients with myotonic muscle disorders.
    Goldemberg AL; Madrid EA; García AM; Roubicek M; Esteban Trucco R
    Invest Clin; 1996 Dec; 37(4):247-53. PubMed ID: 8968130
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Membrane (Na+ + K+)-ATPase of canine brain, heart and kidney. Tissue-dependent differences in kinetic properties and the influence of purification procedures.
    Choi YR; Akera T
    Biochim Biophys Acta; 1978 Apr; 508(2):313-27. PubMed ID: 147705
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glucocorticoid-induced alterations in the sodium potassium pump of the human erythrocyte.
    Kaji DM; Thakkar U; Kahn T
    J Clin Invest; 1981 Aug; 68(2):422-30. PubMed ID: 6267104
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Allosteric transition of erythrocyte alkaline phosphatase from Duchenne muscular dystrophy (DMD) patients and Duchenne muscular dystrophy carriers (Homo sapiens).
    Goldemberg AL; García AM; Fernández H; Fortunato M; Sánchez JJ; Trucco RE
    Int J Biochem; 1988; 20(7):703-6. PubMed ID: 2846381
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Calcium and sodium transport processes in patients with cystic fibrosis. I. A specific decrease in Mg2+-dependent, Ca2+-adenosine triphosphatase activity in erythrocyte membranes from cystic fibrosis patients.
    Katz S
    Pediatr Res; 1978 Nov; 12(11):1033-8. PubMed ID: 214742
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Erythrocyte membrane enzyme abnormalities in two hereditary disorders of muscle.
    Godin DV; Bridges MA; MacLeod PJ
    J Med; 1979; 10(4):287-302. PubMed ID: 231077
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calcium transport and adenosine triphosphatase activities of erythrocyte membranes in congenital spherocytosis.
    Johnsson R; Santaholma S; Saris NE
    Scand J Clin Lab Invest; 1978 Apr; 38(2):121-5. PubMed ID: 148726
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhancement of cardiac actions of ouabain and its binding to Na+, K+-adenosine triphosphatase by increased sodium influx in isolated guinea-pig heart.
    Temma K; Akera T
    J Pharmacol Exp Ther; 1982 Nov; 223(2):490-6. PubMed ID: 6290640
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Erythrocytes in Duchenne muscular dystrophy.
    Siddiqui PQ
    J Pak Med Assoc; 1979 Jul; 29(7):144-50. PubMed ID: 158102
    [No Abstract]   [Full Text] [Related]  

  • 52. Erythrocyte membrane lysophospholipase activity in muscular dystrophy.
    Podolski JL; Lubansky HJ; Sarpel G; Danon MJ; Lazowski E; Omachi A
    J Neurol Sci; 1983 Jun; 59(3):423-9. PubMed ID: 6875608
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Altered component a phosphorylation in erythrocyte membranes in myotonic muscular dystrophy.
    Wong P; Roses AD
    Prog Clin Biol Res; 1978; 21():479-91. PubMed ID: 662903
    [No Abstract]   [Full Text] [Related]  

  • 54. The ATPase activity of saponin-treated rat erythrocytes: regulation by monovalent cations, calcium, ouabain, and furosemide.
    Petrunyaka VV; Panyushkina EA; Severina EP; Orlov SN
    Biochim Biophys Acta; 1990 Dec; 1030(2):279-88. PubMed ID: 2175654
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A monoclonal antibody against horse kidney (Na+ + K+)-ATPase inhibits sodium pump and E2K to E1 conversion of (Na+ + K+)-ATPase from outside of the cell membrane.
    Satoh K; Nakao T; Nagai F; Kano I; Nakagawa A; Ushiyama K; Urayama O; Hara Y; Nakao M
    Biochim Biophys Acta; 1989 Feb; 994(2):104-13. PubMed ID: 2535938
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Uncoupling of ATP binding to Na+,K+-ATPase from its stimulation of ouabain binding: studies of the inhibition of Na+,K+-ATPase by a monoclonal antibody.
    Ball WJ
    Biochemistry; 1986 Nov; 25(22):7155-62. PubMed ID: 3026448
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ATPase activity of erythrocyte membrane in patients with trisomy 21 (Down's syndrome).
    Xue QM; Shen DG; Dong W
    Clin Genet; 1984 Nov; 26(5):429-32. PubMed ID: 6094054
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Erythrocyte membrane in rats fed high erucic acid-containing mustard oil: osmotic fragility, lipid composition, and (Na+, K+)- and (Ca2+, Mg2+)-ATPases.
    Vajreswari A; Rao PS; Kaplay SS; Tulpule PG
    Biochem Med; 1983 Feb; 29(1):74-84. PubMed ID: 6301424
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Palytoxin binds to and inhibits kidney and erythrocyte Na+, K+-ATPase.
    Böttinger H; Habermann E
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Jan; 325(1):85-7. PubMed ID: 6143267
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ischemia-induced alterations in myocardial (Na+ + K+)-ATPase and cardiac glycoside binding.
    Beller GA; Conroy J; Smith TW
    J Clin Invest; 1976 Feb; 57(2):341-50. PubMed ID: 130383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.